OMCL Stock Analysis: Buy, Sell, or Hold?
OMCL - Omnicell Inc
$38.37
-0.31 (-0.81%)
▼
5d:
-4.06%
30d:
-12.33%
90d:
+11.82%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Get Alerted When OMCL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OMCL trading at deep discount. Market pricing in -4.6% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: OMCL trading at deep discount. Market pricing in -4.6% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$67.31
Based on 8.7% avg growth
INTRINSIC VALUE TODAY
$41.79
8.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OMCL is currently trading at $38.37, which is considered oversold relative to its 30-day fair value range of $39.30 to $44.06. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.6) compared to its historical average (20.3). Remarkably, the market is currently pricing in an annual earnings decline of 4.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OMCL is showing sideways momentum. Immediate support is located at $36.55, while resistance sits at $43.52.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.29 (+58.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OMCL is showing sideways momentum. Immediate support is located at $36.55, while resistance sits at $43.52.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.29 (+58.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$39.30 -
$44.06
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 58.4% below Wall St target ($61.29)
Trading Range Analysis
30-Day Trading Range
$39.30 -
$44.06
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$36.55
Resistance Level
$43.52
Current Trend
Sideways
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.62
Wall Street Target
$61.29
(+58.4%)
Revenue Growth (YoY)
14.9%
Earnings Growth (YoY)
-35.9%
Profit Margin
1.7%
Valuation Discount vs History
-4.6% cheaper
PE vs Historical
17.6 vs 20.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.6%
(market-implied from PE analysis)
1-Year Target
$36.90
(-5%)
2-Year Target
$35.20
(-9%)
3-Year Target
$33.58
(-13%)
3-Yr Target (if PE normalizes)
(PE: 18→20)
$38.69
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 13.3%)
$69.51
(+80%)
Base:
(SPY PE: 17.6, Growth: 13.3%)
$56.24
(+45%)
Bear:
(PE: 15.0, Growth: 13.3%)
$47.81
(+24%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Forward PE: 29.50 | Forward EPS (Implied): $1.31
Bull Case
$46.71
(+21%)
Analyst growth 15.0%, PE expands to 31.0
Base Case
$38.68
(0%)
Market implied 0.0%, PE stable at 29.5
Bear Case
$29.59
(-24%)
Severe decline -15.0%, PE contracts to 26.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.6 to 20.3
Stabilization Target:
$44.56
(+15.2%)
PE Expansion Potential:
+15.2%
Share & Embed Analysis
Last updated: June 23, 2026 12:20 PM ET
Data refreshes hourly during market hours. Next update: 1:20 PM
Data refreshes hourly during market hours. Next update: 1:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OMCL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Corey J Manley
SELL
7405 shares
2026-03-16
Corey J Manley
SELL
6106 shares
2026-01-08
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 57 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 55 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$34 | 55 HOLD |
